To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.

Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Arms Length Body Publication (Policy or strategy)
NHS England

Jul. 16 2026

Source Page: Clinical commissioning policy: Delayed-release mercaptamine bitartrate for patients with nephropathic cystinosis (Age > 1 years)
Document: Clinical commissioning policy: Delayed-release mercaptamine bitartrate for patients with nephropathic cystinosis (Age > 1 years) (PDF)
Arms Length Body Publication (Service specification)
NHS England

Jul. 16 2026

Source Page: Clinical commissioning policy: Lonafarnib for Hutchinson-Gilford progeria syndrome (12 months of age and over)
Document: Clinical commissioning policy: Lonafarnib for Hutchinson-Gilford progeria syndrome (12 months of age and over) (PDF)
Arms Length Body Publication (Service specification)
NHS England

Jul. 16 2026

Source Page: Clinical commissioning policy: Prolonged-released (PR) fampridine as a treatment of adults with multiple sclerosis and associated walking impairment
Document: Clinical commissioning policy: Prolonged-released (PR) fampridine as a treatment of adults with multiple sclerosis and associated walking impairment (PDF)
Arms Length Body Publication (Policy or strategy)
NHS England

Jul. 16 2026

Source Page: Clinical commissioning policy: Dabrafenib for BRAFV600E mutation positive histiocytic neoplasms where standard care has failed (all ages)
Document: Clinical commissioning policy: Dabrafenib for BRAFV600E mutation positive histiocytic neoplasms where standard care has failed (all ages) (PDF)
Arms Length Body Publication (Policy or strategy)
NHS England

Jul. 16 2026

Source Page: Clinical commissioning policy: Osilodrostat phosphate for adult patients with endogenous Cushing’s syndrome
Document: Clinical commissioning policy: Osilodrostat phosphate for adult patients with endogenous Cushing’s syndrome (PDF)
Arms Length Body Publication (Policy or strategy)
NHS England

Jul. 16 2026

Source Page: Clinical commissioning policy: Crizotinib for patients with relapsed or refractory ALK-positive ALCL or ALK-positive unresectable IMT
Document: Clinical commissioning policy: Crizotinib for patients with relapsed or refractory ALK-positive anaplastic large cell lymphoma (ALCL) or ALK-positive unresectable inflammatory myofibroblastic tumour (IMT) (PDF)
Arms Length Body Publication (Policy or strategy)
NHS England

Jul. 16 2026

Source Page: Clinical commissioning policy: Sirolimus in extracranial slow-flow vascular malformations refractory to standard therapies
Document: Clinical commissioning policy: sirolimus in extracranial slow-flow vascular malformations refractory to standard therapies (PDF)
Arms Length Body Publication (Published)
NICE

Jul. 15 2026

Source Page: Deuruxolitinib for treating severe alopecia areata
Publication Type: Supporting evidence
Document: Committee papers (PDF 4.06 MB) (webpage)
Arms Length Body Publication (Published)
NICE

Jul. 15 2026

Source Page: Deuruxolitinib for treating severe alopecia areata
Publication Type: Summary PDF
Document: Download guidance (PDF) (webpage)
Arms Length Body Publication (Published)
NICE

Jul. 15 2026

Source Page: Deuruxolitinib for treating severe alopecia areata
Publication Type: Resource impact
Document: Resource impact template (Excel 1.41 MB) (webpage)